{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:23:39Z","timestamp":1790713419981,"version":"4.1.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Scientific Research","award":["23K14942"],"award-info":[{"award-number":["23K14942"]}]},{"name":"Scientific Research","award":["20K17373"],"award-info":[{"award-number":["20K17373"]}]},{"name":"Scientific Research","award":["2459154"],"award-info":[{"award-number":["2459154"]}]},{"name":"Scientific Research","award":["15K09639"],"award-info":[{"award-number":["15K09639"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic graft-versus-host disease (cGVHD) develops with complex interactions between immune cells and cytokines, leading to irreversible fibrosis. Severe cGVHD impairs quality of life and is associated with nonrelapse mortality; however, effective treatments are limited. Recombinant human soluble thrombomodulin (rTM), a novel anticoagulant consisting of the extracellular domains of thrombomodulin, has shown efficacy in patients with transplantation-associated coagulation disorders and, recently, anti-inflammatory properties in animal studies. Here, we investigated the effects of rTM on cGVHD using a sclerodermatous cGVHD (Scl-cGVHD) mouse model. Prophylactic rTM administration suppressed the development of Scl-cGVHD skin lesions both clinically and histopathologically, prolonging event-free and overall survival. The rTM significantly reduced the infiltration of inflammatory cells, including activated T cells and transforming growth factor \u03b21 (TGF\u03b21)-producing macrophages into the skin, while inflammation in the draining lymph nodes during priming phase and in spleen during chronic phase was unaffected. TGF\u03b21 expression in keratinocytes also decreased with rTM. Domain analysis suggested that these effects were mainly attributed to the N-terminal lectin-like domain (domain 1) of rTM, whose functions, including inhibition of inflammatory cell activation and recruitment related to interactions with endothelial cells, has recently been recognized in a limited number of preclinical studies. In conclusion, rTM prevented Scl-cGVHD development, likely by inhibiting the recruitment of inflammatory cells to the skin and subsequent TGF\u03b21 production by keratinocytes. The rTM may represent a novel prophylactic agent for cGVHD.<\/jats:p>","DOI":"10.1093\/jimmun\/vkaf169","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:02:14Z","timestamp":1765641734000},"source":"Crossref","is-referenced-by-count":1,"title":["Recombinant human soluble thrombomodulin prevents murine sclerodermatous chronic graft-versus-host disease"],"prefix":"10.1093","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-4618","authenticated-orcid":false,"given":"Toshihiro","family":"Fujiki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosei","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuaki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Noto General Hospital , Nanao, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7657-272X","authenticated-orcid":false,"given":"Xintao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Fukushima Medical University , Fukushima,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-086X","authenticated-orcid":false,"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Science, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Mase","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raita","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-1766","authenticated-orcid":false,"given":"Yasuhiro","family":"Ikawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Maeba","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9001-6126","authenticated-orcid":false,"given":"Akimasa","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Tsukuba , Tsukuba, Ibaraki,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-0773","authenticated-orcid":false,"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7858-278X","authenticated-orcid":false,"given":"Takayuki","family":"Ikezoe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University , Fukushima,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa, Ishikawa,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8085-4940","authenticated-orcid":false,"given":"Masayuki","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Musashino Red Cross Hospital , Musashino, Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"2026012707071031500_vkaf169-B1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jtct.2021.02.035","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2020 etiology and prevention working group report","volume":"27","author":"Williams","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2026012707071031500_vkaf169-B2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"2026012707071031500_vkaf169-B3","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012707071031500_vkaf169-B4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/hematology.2021000301","article-title":"Updates in chronic graft-versus-host disease","volume":"2021","author":"Hamilton","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2026012707071031500_vkaf169-B5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","article-title":"Recognizing and managing chronic graft-versus-host disease","author":"Lee","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2026012707071031500_vkaf169-B6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026012707071031500_vkaf169-B7","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"key":"2026012707071031500_vkaf169-B8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.det.2019.05.014","article-title":"Review of graft-versus-host disease","volume":"37","author":"Ramachandran","year":"2019","journal-title":"Dermatol Clin"},{"key":"2026012707071031500_vkaf169-B9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","article-title":"Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026012707071031500_vkaf169-B10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bbmt.2010.07.025","article-title":"Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors","volume":"17","author":"Jedlickova","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026012707071031500_vkaf169-B11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.17219\/acem\/126739","article-title":"Secondary skin neoplasms in patients after autologous and allogeneic hematopoietic stem cell transplantation procedures","volume":"29","author":"Szlauer-Stefanska","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"2026012707071031500_vkaf169-B12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"key":"2026012707071031500_vkaf169-B13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0037-1615902","article-title":"Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation","volume":"82","author":"Maruyama","year":"1999","journal-title":"Thromb Haemost"},{"key":"2026012707071031500_vkaf169-B14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2026012707071031500_vkaf169-B15","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"key":"2026012707071031500_vkaf169-B16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ejh.12188","article-title":"Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation","volume":"91","author":"Ikezoe","year":"2013","journal-title":"Eur J Haematol"},{"key":"2026012707071031500_vkaf169-B17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/bmt.2009.242","article-title":"Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin","volume":"45","author":"Sakai","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"2026012707071031500_vkaf169-B18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41409-018-0304-4","article-title":"Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation","volume":"54","author":"Yakushijin","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"2026012707071031500_vkaf169-B19","doi-asserted-by":"crossref","first-page":"101247","DOI":"10.1016\/j.trim.2019.101247","article-title":"Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Nomura","year":"2019","journal-title":"Transpl Immunol"},{"key":"2026012707071031500_vkaf169-B20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/trf.13437","article-title":"Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"56","author":"Fujiwara","year":"2016","journal-title":"Transfusion"},{"key":"2026012707071031500_vkaf169-B21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/cei.12106","article-title":"Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome","volume":"173","author":"Kudo","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"2026012707071031500_vkaf169-B22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1523-1755.2002.00160.x","article-title":"Effects of human soluble thrombomodulin on experimental glomerulonephritis","volume":"61","author":"Ikeguchi","year":"2002","journal-title":"Kidney Int"},{"key":"2026012707071031500_vkaf169-B23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1213\/ANE.0000000000000170","article-title":"Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice","volume":"118","author":"Kawasaki","year":"2014","journal-title":"Anesth Analg"},{"key":"2026012707071031500_vkaf169-B24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/bmt.2014.208","article-title":"Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen","volume":"50","author":"Ikezoe","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"2026012707071031500_vkaf169-B25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2004-01-0328","article-title":"Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease","volume":"104","author":"Anderson","year":"2004","journal-title":"Blood"},{"key":"2026012707071031500_vkaf169-B26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"2026012707071031500_vkaf169-B27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1747.2003.12517.x","article-title":"Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma","volume":"121","author":"Zhang","year":"2003","journal-title":"J Invest Dermatol"},{"key":"2026012707071031500_vkaf169-B28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fimmu.2020.00648","article-title":"Interplay between keratinocytes and fibroblasts: a systematic review providing a new angle for understanding skin fibrotic disorders","volume":"11","author":"Russo","year":"2020","journal-title":"Front Immunol"},{"key":"2026012707071031500_vkaf169-B29","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/jid.2012.226","article-title":"IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease","volume":"132","author":"Le Huu","year":"2012","journal-title":"J Invest Dermatol"},{"key":"2026012707071031500_vkaf169-B30","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jid.2020.09.033","article-title":"IFN-gamma-stimulated apoptotic keratinocytes promote sclerodermatous changes in chronic graft-versus-host disease","volume":"141","author":"Saito","year":"2021","journal-title":"J Invest Dermatol"},{"key":"2026012707071031500_vkaf169-B31","doi-asserted-by":"crossref","first-page":"945063","DOI":"10.3389\/fimmu.2022.945063","article-title":"Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis","volume":"13","author":"Kokubo","year":"2022","journal-title":"Front Immunol"},{"key":"2026012707071031500_vkaf169-B32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1538-7836.2011.04319.x","article-title":"Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation","volume":"9 Suppl 1","author":"Ito","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2026012707071031500_vkaf169-B33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/med.21294","article-title":"Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications","volume":"34","author":"Wang","year":"2014","journal-title":"Med Res Rev"},{"key":"2026012707071031500_vkaf169-B34","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"2026012707071031500_vkaf169-B35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1538-7836.2012.04621.x","article-title":"Exogenous activated protein C inhibits the progression of diabetic nephropathy","volume":"10","author":"Gil-Bernabe","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2026012707071031500_vkaf169-B36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/jth.13182","article-title":"Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism","volume":"14","author":"Shaya","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2026012707071031500_vkaf169-B37","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"2026012707071031500_vkaf169-B38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-19-34","article-title":"The role of thrombomodulin lectin-like domain in inflammation","volume":"19","author":"Li","year":"2012","journal-title":"J Biomed Sci"},{"key":"2026012707071031500_vkaf169-B39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00403-013-1401-2","article-title":"Ultraviolet light exposure stimulates HMGB1 release by keratinocytes","volume":"305","author":"Johnson","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"2026012707071031500_vkaf169-B40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"2026012707071031500_vkaf169-B41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2026012707071031500_vkaf169-B42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2796.2003.01296.x","article-title":"Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function","volume":"255","author":"Muller","year":"2004","journal-title":"J Intern Med"},{"key":"2026012707071031500_vkaf169-B43","doi-asserted-by":"crossref","first-page":"20699","DOI":"10.1073\/pnas.1320808110","article-title":"Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection","volume":"110","author":"Yanai","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012707071031500_vkaf169-B44","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/ATVBAHA.107.150631","article-title":"Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes","volume":"28","author":"Ito","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012707071031500_vkaf169-B45","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1161\/ATVBAHA.113.301221","article-title":"Recombinant lectin-like domain of thrombomodulin suppresses vascular inflammation by reducing leukocyte recruitment via interacting with Lewis Y on endothelial cells","volume":"33","author":"Lin","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012707071031500_vkaf169-B46","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"2026012707071031500_vkaf169-B47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jb\/118.5.1030","article-title":"The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function","volume":"118","author":"Honda","year":"1995","journal-title":"J Biochem"},{"key":"2026012707071031500_vkaf169-B48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jphs.2020.01.001","article-title":"Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in vivo","volume":"143","author":"Nishizawa","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"2026012707071031500_vkaf169-B49","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1538-7836.2006.02033.x","article-title":"The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis","volume":"4","author":"Van de Wouwer","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2026012707071031500_vkaf169-B50","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.4049\/jimmunol.120.5.1485","article-title":"Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man","volume":"120","author":"Tsoi","year":"1978","journal-title":"J Immunol"},{"key":"2026012707071031500_vkaf169-B51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13287-020-01768-7","article-title":"CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model","volume":"11","author":"Lim","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"2026012707071031500_vkaf169-B52","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.exphem.2016.02.002","article-title":"Effect of roflumilast, novel phosphodiesterase-4 inhibitor, on lung chronic graft-versus-host disease in mice","volume":"44","author":"Kim","year":"2016","journal-title":"Exp Hematol"},{"key":"2026012707071031500_vkaf169-B53","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1111\/bph.15153","article-title":"Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx","volume":"177","author":"Suzuki","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2026012707071031500_vkaf169-B54","first-page":"1971","article-title":"HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE\/NF-kappaB\/HPSE signaling to enhance latent TGF-beta release from ECM","volume":"8","author":"He","year":"2016","journal-title":"Am J Transl Res"},{"key":"2026012707071031500_vkaf169-B55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/resp.13514","article-title":"Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias","volume":"24","author":"Arai","year":"2019","journal-title":"Respirology"},{"key":"2026012707071031500_vkaf169-B56","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000558","article-title":"Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial","volume":"7","author":"Arai","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"2026012707071031500_vkaf169-B57","doi-asserted-by":"crossref","first-page":"102390","DOI":"10.1016\/j.jaut.2019.102390","article-title":"Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection","volume":"108","author":"Watanabe-Kusunoki","year":"2020","journal-title":"J Autoimmun"},{"key":"2026012707071031500_vkaf169-B58","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/ATVBAHA.112.251157","article-title":"Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase\/myeloid leukemia cell-1 signaling","volume":"32","author":"Ikezoe","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026012707071031500_vkaf169-B59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1667\/RR14408.1","article-title":"Recombinant thrombomodulin (solulin) ameliorates early intestinal radiation toxicity in a preclinical rat model","volume":"186","author":"Pathak","year":"2016","journal-title":"Radiat Res"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/1\/vkaf169\/65877662\/vkaf169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/215\/1\/vkaf169\/65877662\/vkaf169.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:07:26Z","timestamp":1769515646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/doi\/10.1093\/jimmun\/vkaf169\/8379562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,13]]},"published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jimmun\/vkaf169","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,12,13]]},"article-number":"vkaf169"}}